KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Gross Margin (2016 - 2026)

Idexx Laboratories has reported Gross Margin over the past 17 years, most recently at 60.35% for Q4 2025.

  • For Q4 2025, Gross Margin rose 55.0% year-over-year to 60.35%; the TTM value through Dec 2025 reached 61.8%, up 76.0%, while the annual FY2025 figure was 61.8%, 76.0% up from the prior year.
  • Gross Margin for Q4 2025 was 60.35% at Idexx Laboratories, down from 61.83% in the prior quarter.
  • Over five years, Gross Margin peaked at 62.62% in Q2 2025 and troughed at 56.97% in Q4 2021.
  • A 5-year average of 60.19% and a median of 60.26% in 2023 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: skyrocketed 312bps in 2021 and later crashed -91bps in 2022.
  • Year by year, Gross Margin stood at 56.97% in 2021, then increased by 3bps to 58.53% in 2022, then decreased by 0bps to 58.36% in 2023, then increased by 2bps to 59.8% in 2024, then rose by 1bps to 60.35% in 2025.
  • Business Quant data shows Gross Margin for IDXX at 60.35% in Q4 2025, 61.83% in Q3 2025, and 62.62% in Q2 2025.